Physician

John Paul Salerno, D.O.

According to 2025 Medicare claims, John Salerno, D.O. (NPI: 1285746669) practices osteopathic manipulative therapy in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Passaic, NJ. This provider's primary affiliated billing organization is MOUNTAIN CREST MEDICAL LLC (NPI: 1255907663) and primary practice location at 07011-9998.

Salerno's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 531 traditional Medicare patients, billed 5,769 HCPCS/CPT codes, and received $7,470,899 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 466 prescription claims across 159 beneficiaries totaling $34,680 in drug costs, led by Fosfomycin Tromethamine (Fosfomycin Tromethamine). Open Payments data shows 36 records totaling $1,768. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $17,214 to $34,680. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.7M$7.5M2021 Medicare payment: $41,984 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $82,409 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $147,497 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $7,470,899 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20215501,239$41,984
20223372,025$82,409
20235973,631$147,497
20245315,769$7,470,899

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$17K$35K2015 Drug cost: $17,214 (USD; Tot_Drug_Cst)2016 Drug cost: $11,748 (USD; Tot_Drug_Cst)2017 Drug cost: $9,774 (USD; Tot_Drug_Cst)2018 Drug cost: $4,603 (USD; Tot_Drug_Cst)2019 Drug cost: $3,212 (USD; Tot_Drug_Cst)2020 Drug cost: $5,380 (USD; Tot_Drug_Cst)2021 Drug cost: $29,055 (USD; Tot_Drug_Cst)2022 Drug cost: $4,273 (USD; Tot_Drug_Cst)2023 Drug cost: $23,433 (USD; Tot_Drug_Cst)2024 Drug cost: $34,680 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201514168$17,214
201614173$11,748
201713156$9,774
201813110$4,603
2019N/R71$3,212
20201970$5,380
202127119$29,055
20222362$4,273
2023103304$23,433
2024159466$34,680

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2157$112
99342Residence visit for new patient with low level of medical decision making, per day, if using time, at least 30 minutes290290$60
99348Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes354832$59
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less21149$57
36415Insertion of needle into vein for collection of blood sample3142$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Fosfomycin TromethamineFosfomycin Tromethamine2828$2,117
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst73386$1,689
Np ThyroidThyroid,pork13870$931
Estradiol (Twice Weekly)Estradiol12664$907
ProgesteroneProgesterone, Micronized331,775$768

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.36$1,768PolyNovo North America LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Paul Salerno, D.O.?

Tedicare shows public-source Medicare data for John Paul Salerno, D.O. (NPI 1285746669), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Paul Salerno, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Paul Salerno, D.O.?

John Paul Salerno, D.O. is linked to MOUNTAIN CREST MEDICAL LLC (billing NPI 1255907663) in the available physician profile data.

Does John Paul Salerno, D.O. have Open Payments data?

John Paul Salerno, D.O. has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.